Patient Rating:

No Rating Available?

Kristi J. Smock, M.D.

Patient Rating:

No Rating Available?

Specialties

Languages

  • English

Clinical Details

Phone Number Clinical Office Address

Specialties

Bio

Dr. Smock is currently an Associate Professor in the Department of Pathology at the University of Utah. She completed her residency and fellowship training at the University of Utah and is board certified in Anatomic and Clinical Pathology and Hematopathology. She has a particular interest in Coagulation Medicine and is Medical Director of the Hemostasis/Thrombosis Laboratory at ARUP where she enjoys being involved in all aspects of the laboratory. She particularly enjoys making contributions to patient care by consulting on difficult coagulation cases. She has additional clinical service responsibilities in Hematopathology, where she signs out bone marrow cases. Dr. Smock enjoys teaching and serves as the Associate Residency Program Director for the Department of Pathology and Chair of the Resident Clinical Competency Committee. As Rotation Director for the resident and fellow rotations in Coagulation Medicine, she is actively involved in resident and fellow training, and she received the Outstanding Teaching Award in Clinical Pathology in 2010 and 2013. Dr. Smock is also involved in teaching medical students at the University of Utah during their Hematology curriculum. She is also the course director for PATH 7020, the medical student rotation in Clinical Pathology and serves on the Undergraduate Medical Education Committee for the Department of Pathology. She has many research interests in Coagulation Medicine including ongoing projects related to elevations of coagulation factors and association with thrombotic risk.

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Sub: Hematology)
American Board of Pathology (Anatomic & Clinical)

Academic Profile

Research Interests

  • Reference intervals for coagulation factors
  • Factor IX
  • Factor XI
  • Heparin-Induced Thrombocytopenia (HIT)
  • Lupus anticoagulants

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Sub: Hematology)
American Board of Pathology (Anatomic & Clinical)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 583-2787 Ext 2154 ARUP
Medical Directors
500 Chipeta Way
Salt Lake City, UT 84108

Academic Bio

Dr. Smock is an Associate Professor in the Department of Pathology at the University of Utah and Medical Director of the Hemostasis/Thrombosis Laboratory. She received her MD from the University of Utah and also completed her residency training in Anatomic and Clinical Pathology and fellowship training in Hematopathology at the University of Utah. She is board certified in Anatomic and Clinical pathology by the American Board of Pathology, with subspecialty certification in Hematology.

Education

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Hematopathology
Fellow
Residency University of Utah School of Medicine
Pathology
Resident
Professional Medical University of Utah
Medicine
M.D.
Undergraduate Utah State University
Biology
B.S.

Publications

Selected Provider Publications

Journal Article

  1. Zantek ND, Hsu P, Meijer P, Smock KJ, Plumhoff EA, Refaai MA, Van Cott EM (2015). Quality of factor XI activity testing in North American Specialized Coagulation Laboratories. Int J Lab Hematol, 37 Suppl 1, 99-107.
  2. Desai DS, Lyon E, Rodgers GM, Jama MA, Wallentine SL, Smock KJ (2015). Elderly Female with a Personal and Family History of a Bleeding Disorder. Clin Chem, 61(7), 909-12.
  3. Hsu P, Zantek ND, Meijer P, Hayward CP, Brody J, Zhang X, Smock KJ, Van Cott EM (2014). Factor XIII Assays and Associated Problems for Laboratory Diagnosis of Factor XIII Deficiency: An Analysis of International Proficiency Testing Results. Semin Thromb Hemost, 40(2), 232-8.
  4. Smock KJ, Ledford-Kraemer MR, Meijer P, Hsu P, Van Cott EM (2014). Proficiency testing results for heparin-induced thrombocytopenia in north america. Semin Thromb Hemost, 40(2), 254-60.
  5. Smock KJ, Agarwal AM, Lim MS, Tripp SR, Miles RR, Patel JL, Abromowitch M, Lones MA, Cairo MS, Perkins SL (2014). Expression of Notch1 and mTOR Pathway Proteins in Pediatric Lymphoblastic Lymphoma; A Children’s Oncology Group Report. Journal of Hematopathology, 7(1), 9-14.
  6. Smock KJ, Schmidt RL, Hadlock G, Stoddard G, Grainger D, Munger MA (2014). Assessment of orally-dosed commercial silver nanoparticles on human ex vivo platelet aggregation. Nanotoxicology, 8(3), 328-33.
  7. Heikal NM, Murphy KK, Crist RA, Wilson AR, Rodgers GM, Smock KJ (2013). Elevated factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic events. Am J Clin Pathol, 140(5), 680-5.
  8. Heikal NM, Smock KJ (2013). Laboratory testing for platelet antibodies. Am J Hematol, 88(9), 818-21.
  9. Pandey S, Post SR, Alapat DV, Smock KJ, Post GR (2013). Prolonged prothrombin time correlates with serum immunoglobulin levels in patients with plasma cell dyscrasia. Int J Lab Hematol, 35, 421-27.
  10. Shirts BH, Rodgers GM, Smock KJ (2012). Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer. Thromb Res, 130(3), e134-8.
  11. Tantravahi SK, Williams LB, Digre KB, Creel DJ, Smock KJ, Deangelis MM, Clayton FC, Vitale AT, Rodgers GM (2012). An inherited disorder with splenomegaly, cytopenias, and vision loss. Am J Med Genet A, 158A(3), 475-81.
  12. Smock KJ, Saunders PJ, Rodgers GM, Johari V (2011). Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods. Am J Hematol, 86(12), 1032-34.
  13. Sangle NA, Agarwal AM, Smock KJ, Leavitt MO, Warnke R, Bahler D, Perkins SL (2011). Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7. Appl Immunohistochem Mol Morphol, 19(6), 579-83.
  14. Wilcox R, Pendleton RC, Smock KJ, Rodgers GM (2011). Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice. Hosp Pract (Minneap), 39(3), 23-34.
  15. Sangle NA, Rodgers GM, Smock KJ (2011). Prevalence of heparin in samples submitted for lupus anticoagulant testing. Lab Hematol, 17(1), 6-11.
  16. Smock KJ, Rodgers GM (2010). Laboratory evaluation of aspirin responsiveness. Am J Hematol, 85(5), 358-60.
  17. Smock KJ, Crist RA, Hansen SJ, Rodgers GM, Lehman CM (2010). Discard tubes are not necessary when drawing samples for specialized coagulation testing. Blood Coagul Fibrinolysis, 21(3), 279-82.
  18. Penmetsa GK, Rodgers GM, Smock KJ (2010). Avoiding errors in the laboratory evaluation of potent lupus anticoagulants. Am J Hematol, 85(4), 272-4.
  19. Crist RA, Gibbs K, Rodgers GM, Smock KJ (2009). Effects of EDTA on routine and specialized coagulation testing and an easy method to distinguish EDTA-treated from citrated plasma samples. Lab Hematol, 15(4), 45-8.
  20. Smock KJ, Rodgers GM (2009). Laboratory identification of lupus anticoagulants. Am J Hematol, 84(7), 440-442.
  21. Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, Perkins SL (2008). Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatr Blood Cancer, 51(4), 489-94.
  22. Smock KJ, Perkins SL, Bahler DW (2007). Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment. Arch Pathol Lab Med, 131(6), 951-5.
  23. Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ (2006). Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer, 47(2), 130-40.
  24. Herron MD, Vanderhooft SL, Smock K, Zhou H, Leachman SA, Coffin C (2004). Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis. Am J Surg Pathol, 28(8), 1017-25.
  25. Streiff MB, Holmstrom B, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenniger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Want TF, Yee GC Zakarija A, McMillian N, Engh AM (In Press). Cancer-associated venous thromboembolic disease, featured updates to the NCCN Guidelines. J Natl Compr Canc Netw.
  26. Staddon JH, Smock KJ, Schiffman JD, Fluchel MN, Engel ME, Weyrich AS, Campbell RA (In Press). Pegasparaginase treatment alters thrombin generation by modulating the protein C and S system in acute lymphoblastic leukemia/lymphoma. Blood Coagul Fibrinolysis.

Review

  1. Smock KJ, Perkins SL (2014). Thrombocytopenia: an update. [Review]. Int J Lab Hematol, 36(3), 269-78.
  2. Sangle NA, Smock KJ (2011). Antiphospholipid antibody syndrome. [Review]. Archives of Pathology & Laboratory Medicine, 135(9), 1092-6.
  3. Tebo AE, Smock KJ, Branch WD (2011). Laboratory diagnostic assays for antiphospholipid syndrome. [Review]. ASCP CheckSample Series- Clinical Chemistry, 51(3).

Book Chapter

  1. Smock KJ (2015). Pharmacogenetic Testing for Anticoagulant and Antiplatelet therapies. In Bennett ST, Lehman CM, Rodgers GM (Ed.), Laboratory Hemostasis (2). New York City: Springer.
  2. Smock KJ, Perkins SL (2013). Examination of the Blood and Bone Marrow. In Greer, Arber, Glader, List, Means, Paraskevas, Rodgers (Ed.), Wintrobe's Clinical Hematology (13). Philadelphia: Lippincott Williams & Wilkins.
  3. Smock KJ, Heikal NM (In Press). Laboratory Assays for ADAMTS-13. In Rodgers GM (Ed.), ADAMTS-13: Biology and Disease (1). New York City: Springer.

Case Report

  1. Smock KJ, Yaish HM, Cairo MS, Lones MA, Willmore-Payne C, Perkins SL (2007). Mantle cell lymphoma presenting with unusual morphology in an adolescent female: a case report and review of the literature. Pediatr Dev Pathol, 10(5), 403-8.

Abstract

  1. Sono-Koree N, Crist RA, Heikal NM, Rodgers GM, Smock KJ (2015). A high-performance liquid chromatography method for the serotonin release assay is equivalent to the radioactive method [Abstract]. Int J Lab Hematol, 2015(Supp 2), 1-130, #24.
  2. Crist RA, Sono-Koree N, Heikal NM, Rodgers GM, Smock KJ (2015). Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Improves the Quantitation of Factor XIII Activity [Abstract]. Int J Lab Hematol, 37(Supp 2), 1-130, #201.
  3. Heikal NM, Crist RA, Rodgers GM, Smock KJ (2015). The serotonin release assay should be the first-line test for heparin-induced thrombocytopenia in patients with antiphospholipid antibodies [Abstract]. Int J Lab Hematol, 37(Supp 2), 1-130, #214.
  4. Staddon J, Smock K, Schiffman J, Engel M, Fluchel M, Weyrich A (2014). Pegasparaginase treatment in pediatric acute lymphoblastic malignancy alters thrombin generation through modulation of the protein C and S system [Abstract]. Pediatr Blood Cancer, 61(S1), S1-104.

Poster

  1. Heikal NM, Crist RA, Rodgers GM, Smock KJ (2015). The serotonin release assay should be the first-line test for heparin-induced thrombocytopenia in patients with antiphospholipid antibodies. Poster session presented at International Society for Laboratory Hematology 2015, XXVIIIth International Symposium on Technological Innovations in Laboratory Hematology, Chicago, IL.
  2. Crist RA, Sono-Koree N, Heikal NM, Rodgers GM, Smock KJ (2015). Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Improves the Quantitation of Factor XIII Activity. Poster session presented at International Society for Laboratory Hematology 2015, XXVIIIth International Symposium on Technological Innovations in Laboratory Hematology, Chicago, IL.

Clinical Trials

Video & News